In focus
Latest feed
The Global Weight Challenge: Navigating the WHO's New Stance on GLP-1 Medicines
A Global Shift: WHO Declares Obesity a Chronic Disease, Backs GLP-1 Drugs with Holistic Care
A Global Health Crossroads: WHO's Conditional Embrace of Ozempic-Class Drugs for Obesity
GLP-1 Medications: A Game-Changer, But Not a Solo Act – The WHO Weighs In
